All news

Most vulnerable populations remain the hardest hit

10 December 2014

MMV and partners build a strong portfolio of new PfATP4 inhibitors in translational medicine ready for clinical development

09 December 2014

Collaborations set to advance life-saving pre-referral treatment for severe malaria

27 November 2014

RBM seeks input for the second Global Malaria Action Plan

20 November 2014

Coartem® Dispersible was developed by Novartis and MMV to change the way children with malaria are treated

19 November 2014

Recognition of project in collaboration with MMV and DNDi to optimize new compounds for parasitic diseases

13 November 2014

First delivery of this life-saving drug made through MMV-led UNITAID-funded "Improving Severe Malaria Outcomes" project

04 November 2014

WHO-prequalified seasonal malaria chemoprevention will now be available to countries  

29 October 2014

New treatment will contribute to WHO’s artemisinin resistance containment strategy

15 October 2014

Partner and staunch supporter of MMV, Dr Rogers will be sorely missed

09 September 2014